Clinical Trial Update: Phase IIb Study of Intranasal Glutathione in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase IIb trial evaluating intranasal glutathione for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intranasal glutathione (glutathione)

Snippet

Sponsor: Bastyr University | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED